Moffitt Joins National Cancer Institute to Endorse Updated HPV Vaccination for Cancer Prevention

TAMPA, Fla. – Recognizing a critical need to improve national vaccination rates for the human papillomavirus (HPV), Moffitt Cancer Center has again united with each of the 69 National Cancer Institute-designated cancer centers in issuing a joint statement in support of recently revised recommendations from the Centers for Disease Control and Prevention (CDC).